Patent Assignment
Reel/Frame 061089/0259
Change of Name
Recorded: 2022-09-14
Pages: 2
Assignor
TEKMIRA PHARMACEUTICALS CORPORATION
Executed: 2015-07-31
Assignee
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Properties
(2)
Screening Method for Selected Amino-Lipid-Containing Compositions
Application:
16/442,191 →
Publication:
US 2020/0225215
Screening Method for Selected Amino-Lipid-Containing Compositions
Application:
17/221,457 →
Publication:
US 2022/0074925
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 17, 2021
From: ALNYLAM PHARMACEUTICALS, INC
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 055627/0105 →
Assignment of Assignor's Interest
Sep 12, 2022
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 061064/0594 →
Merger
Sep 15, 2022
From: PROTIVA BIOTHERAPEUTICS, INC.
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 061434/0735 →